1. Home
  2. JAMF vs MDXG Comparison

JAMF vs MDXG Comparison

Compare JAMF & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JAMF
  • MDXG
  • Stock Information
  • Founded
  • JAMF 2002
  • MDXG 2006
  • Country
  • JAMF United States
  • MDXG United States
  • Employees
  • JAMF N/A
  • MDXG N/A
  • Industry
  • JAMF Computer Software: Prepackaged Software
  • MDXG Biotechnology: Pharmaceutical Preparations
  • Sector
  • JAMF Technology
  • MDXG Health Care
  • Exchange
  • JAMF Nasdaq
  • MDXG Nasdaq
  • Market Cap
  • JAMF 1.4B
  • MDXG 1.2B
  • IPO Year
  • JAMF 2020
  • MDXG N/A
  • Fundamental
  • Price
  • JAMF $10.82
  • MDXG $6.68
  • Analyst Decision
  • JAMF Buy
  • MDXG Strong Buy
  • Analyst Count
  • JAMF 9
  • MDXG 3
  • Target Price
  • JAMF $20.00
  • MDXG $12.00
  • AVG Volume (30 Days)
  • JAMF 873.5K
  • MDXG 587.5K
  • Earning Date
  • JAMF 05-06-2025
  • MDXG 04-30-2025
  • Dividend Yield
  • JAMF N/A
  • MDXG N/A
  • EPS Growth
  • JAMF N/A
  • MDXG N/A
  • EPS
  • JAMF N/A
  • MDXG 0.28
  • Revenue
  • JAMF $627,399,000.00
  • MDXG $348,879,000.00
  • Revenue This Year
  • JAMF $10.07
  • MDXG $10.04
  • Revenue Next Year
  • JAMF $8.94
  • MDXG $11.53
  • P/E Ratio
  • JAMF N/A
  • MDXG $23.86
  • Revenue Growth
  • JAMF 11.92
  • MDXG 8.52
  • 52 Week Low
  • JAMF $9.95
  • MDXG $5.47
  • 52 Week High
  • JAMF $21.41
  • MDXG $10.14
  • Technical
  • Relative Strength Index (RSI)
  • JAMF 34.69
  • MDXG 32.24
  • Support Level
  • JAMF $10.76
  • MDXG $6.55
  • Resistance Level
  • JAMF $11.40
  • MDXG $7.34
  • Average True Range (ATR)
  • JAMF 0.58
  • MDXG 0.36
  • MACD
  • JAMF 0.01
  • MDXG -0.04
  • Stochastic Oscillator
  • JAMF 31.76
  • MDXG 15.75

About JAMF Jamf Holding Corp.

Jamf Holding Corp is the standard in Apple Enterprise Management, and its cloud software platform is the vertically focused Apple infrastructure and security platform. The company helps organizations, including businesses, hospitals, schools, and government agencies, connect, manage, and protect Apple products, apps, and corporate resources in the cloud without ever having to touch the devices. It sells its Software-as-a-Service, or SaaS, solutions via a subscription model, through a direct sales force, online, and indirectly via its channel partners, including Apple. The company operates in The Americas; Europe, the Middle East, India, and Africa; and Asia Pacific.

About MDXG MiMedx Group Inc

MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are primarily targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.

Share on Social Networks: